Duloxetine in the Prevention of Depressive Recurrences
David Pérahia(École Normale Supérieure Paris-Saclay), Michael J. Detke(Eli Lilly (United States)), Giuseppe Maina(Ospedale San Luigi Gonzaga), Daniel Walker(University of Bradford), Melissa E. Spann, Fujun Wang(East China University of Science and Technology), Michael E. Thase(Veterans Health Administration)
Cited by 48
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k